Price$15.34-0.21 (-1.38%)
01:30 PM07:45 PM
News · 26 weeks75+88%
2025-10-262026-04-19
Mix5290d
- Insider29(56%)
- Other9(17%)
- SEC Filings7(13%)
- Earnings3(6%)
- Offering3(6%)
- Analyst1(2%)
Latest news
25 items- SECSEC Form DEFA14A filed by Hercules Capital Inc.DEFA14A - Hercules Capital, Inc. (0001280784) (Filer)
- SECSEC Form DEF 14A filed by Hercules Capital Inc.DEF 14A - Hercules Capital, Inc. (0001280784) (Filer)
- PRHercules Capital Announces Date for Release of First Quarter 2026 Financial Results and Conference CallHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2026 financial results conference call for Tuesday, May 5, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of our
- INSIDERSEC Form 4 filed by Botelho Kiersten Zaza4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Follmann Christian4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Meyer Seth H4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Bluestein Scott4 - Hercules Capital, Inc. (0001280784) (Issuer)
- PRHercules Capital Sets New Record with All-Time High New Debt and Equity CommitmentsHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced it has set a new all-time record of $1.81 billion in new debt and equity commitments for the first quarter of 2026. "Coming off a record-breaking performance for gross new debt and equity commitments and fundings in 2025, our momentum accelerated in Q1 — marked by an all-time high in new debt and equity commitments," said Scott Bluestein, chief executive officer and chief investment o
- INSIDERSEC Form 4 filed by Badavas Robert P4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Loo Wade4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Fallon Thomas J4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Aguirre Deanne4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Randhawa Paramjeet K4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Crowell Gayle A4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERSEC Form 4 filed by Theodosopoulos Nikos4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERChief Financial Officer Meyer Seth H covered exercise/tax liability with 5 shares, decreasing direct ownership by 0.00% to 448,548 units (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- PRenGene Reports First Quarter 2026 Financial Results and Provides Business UpdateLEGEND pivotal cohort update planned for a spring 2026 medical conference 12-month complete response data from LEGEND pivotal cohort expected in 2H 2026 Biologics License Application (BLA) submission for detalimogene planned for 2H 2026 Cash and marketable securities of $312.5 million expected to provide cash runway into 2H 2028 Expanded $125 million debt facility with Hercules Capital provides additional financial flexibility to advance detalimogene development and commercialization for bladder cancer enGene Holdings Inc. (NASDAQ:ENGN, "enGene" or the "Company")), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the first quarter en
- INSIDERAmendment: Chief Operating Officer Follmann Christian bought $73,400 worth of shares (5,000 units at $14.68), increasing direct ownership by 3% to 150,135 units (SEC Form 4)4/A - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERChief Operating Officer Follmann Christian decreased direct ownership by 3% to 150,135 units (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- INSIDERDirector Randhawa Paramjeet K bought $45,079 worth of shares (3,050 units at $14.78), increasing direct ownership by 18% to 19,560 units (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- PRHercules Capital Receives a BBB (high) Affirmed Investment Grade Corporate and Credit Rating from Morningstar DBRSHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS ("DBRS") has affirmed Hercules' investment grade corporate and credit rating of BBB (high). DBRS issued a statement announcing the affirmation of the rating and Stable trend, as well as its underlying analysis. According to DBRS, the affirmed BBB (high) credit ratings reflect the Company's well-developed franchise and strong operating performance including resili
- INSIDERAmendment: Chief Financial Officer Meyer Seth H bought $200,620 worth of shares (14,000 units at $14.33), increasing direct ownership by 3% to 448,553 units (SEC Form 4)4/A - Hercules Capital, Inc. (0001280784) (Issuer)
- PRHercules Capital Named 2025 Americas BDC Manager of the Year by Private Debt InvestorHercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, was named 2025 BDC Manager of the Year - Americas by Private Debt Investor magazine. Each year, the PDI Awards acknowledge the best firms and deals across global, Americas, European and Asia-Pacific markets. After initial nominations, the PDI editorial team votes on a select group of finalists across 50-plus categories. PDI noted that in a year marked by political uncertainty, tightness in capital ma
- INSIDERDirector Theodosopoulos Nikos bought $36,946 worth of shares (2,600 units at $14.21), increasing direct ownership by 14% to 21,523 units (SEC Form 4)4 - Hercules Capital, Inc. (0001280784) (Issuer)
- SECSEC Form ABS-15G filed by Hercules Capital Inc.ABS-15G - Hercules Capital, Inc. (0001280784) (Filer)